Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Costs and expenses        
Operating costs $ 2,411 $ 1,793 $ 4,541 $ 3,476
Research and development 224 9 771 357
Selling, general and administrative 7,259 1,048 14,883 2,286
Total operating costs and expenses 9,894 2,850 20,195 6,119
Interest expense 6,054 597 12,143 1,185
Change in fair value of warrants (359) 1,120 13,262 1,775
Other expense (312) (152) (203) (100)
Total other expense 5,383 1,565 25,202 2,860
Net loss $ (15,277) $ (4,415) $ (45,397) $ (8,979)
Loss per share        
Basic (in usd per share) $ (0.13) $ (0.19) $ (0.54) $ (0.48)
Diluted (in usd per share) $ (0.13) $ (0.19) $ (0.54) $ (0.48)
Weighted average common shares        
Basic (in shares) 117,346 27,156 84,284 27,156
Diluted (in shares) 117,346 27,156 84,284 27,156
Other comprehensive loss:        
Unrealized loss on debt securities available for sale $ (106) $ 0 $ (106) $ 0
Total comprehensive loss $ (15,383) $ (4,415) $ (45,503) $ (8,979)